Neuregulin 1: A prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models

Frontiers in Behavioral Neuroscience

Volumn , Issue JUL, 2013, Pages

  Karl, Tim ^a,b,c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b Schizophrenia Research Institute   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Enrichment; Gene environment interactions; Housing; Mouse; Neuregulin 1; Rat; Schizophrenia; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABIS; CATECHOL METHYLTRANSFERASE; CONCANAVALIN A; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEU DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BIOLOGICAL FUNCTIONS; CANNABIS ADDICTION; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; DOWN REGULATION; ENVIRONMENTAL ENRICHMENT; GENE EXPRESSION; GENE MUTATION; GENOTYPE ENVIRONMENT INTERACTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MENTAL STRESS; NEGATIVE FEEDBACK; NONHUMAN; NRG1 GENE; PREFRONTAL CORTEX; PROTEIN PHOSPHORYLATION; REVIEW; SCHIZOPHRENIA; SPATIAL MEMORY; SYNAPSE; UPREGULATION;

EID: 84882689092     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00106     Document Type: Review

References (108)

1. Almli, C. R., Levy, T. J., Han, B. H., Shah, A. R., Gidday, J. M., and Holtzman, D. M. (2000). BDNF protects against spatial memory defi{ligature}cits following neonatal hypoxia-ischemia. Exp. Neurol. 166, 99-114. doi: 10. 1006/exnr.2000.7492
2. Andersen, S. L., Thompson, A. T., Rutstein, M., Hostetter, J. C., and Teicher, M. H. (2000). Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37, 167-169.
3. Arnold, J. C., Boucher, A. A., and Karl, T. (2012). The yin and yang of cannabis-induced psychosis: the actions of Delta(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Curr. Pharm. Des. 18, 5113-5130. doi: 10. 2174/138161212802884726
4. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., and Moffi{ligature}tt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325, 1212-1213. doi: 10.1136/bmj.325.7374.1212
5. Arseneault, L., Cannon, M., Witton, J., and Murray, R. M. (2004). Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 184, 110-117. doi: 10.1192/bjp.184.2.110
6. Asan, E., Yilmazer-Hanke, D. M., Eliava, M., Hantsch, M., Lesch, K. P., and Schmitt, A. (2005). The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131, 953-967. doi: 10.1016/j. neuroscience.2004.11.040
7. Ayhan, Y., Sawa, A., Ross, C. A., and Pletnikov, M. V. (2009). Animal models of gene-environment interactions in schizophrenia. Behav. Brain Res. 204, 274-281. doi: 10.1016/j.bbr.2009.04.010
8. Balu, D. T., and Coyle, J. T. (2011). Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci. Biobehav. Rev. 35, 848-870. doi: 10.1016/j.neubiorev.2010.10.005
9. Bayer, T. A., Falkai, P., and Maier, W. (1999). Genetic and nongenetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis. " J. Psychiatr. Res. 33, 543-548. doi: 10.1016/S0022-3956(99) 00039-4
10. Benaroya-Milshtein, N., Hollander, N., Apter, A., Kukulansky, T., Raz, N., Wilf, A., et al. (2004). Environmental enrichment in mice decreases anxiety-like, attenuates stress responses and enhances natural killer cell activity. Eur. J. Neurosci. 20, 1341-1347. doi: 10.1111/j.1460-9568.2004.03587.x
11. Berton, O., McClung, C. A., Dileone, R. J., Krishnan, V., Renthal, W., Russo, S. J., et al. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868. doi: 10.1126/science.1120972
12. Bjarnadottir, M., Misner, D. L., Haverfi{ligature}eld-Gross, S., Bruun, S., Helgason, V. G., Stefansson, H., et al. (2007). Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/-knock-outs compared with wild-type mice. J. Neurosci. 27, 4519-4529. doi: 10.1523/JNEUROSCI.4314-06.2007
13. Boucher, A. A., Arnold, J. C., Duffy, L., Schofi{ligature}eld, P. R., Micheau, J., and Karl, T. (2007a). Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology (Berl.) 192, 325-336. doi: 10.1007/s00213-007-0721-3
14. Boucher, A. A., Hunt, G. E., Karl, T., Micheau, J., McGregor, I. S., and Arnold, J. C. (2007b). Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience 149, 861-870. doi: 10.1016/ j.neuroscience.2007.08.020
15. Boucher, A. A., Hunt, G. E., Micheau, J., Huang, X., McGregor, I. S., Karl, T., et al. (2011). The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. Int. J. Neuropsychopharmacol. 14, 631-643. doi: 10.1017/S1461 14571000091X
16. Bowling, S. L., Rowlett, J. K., and Bardo, M. T. (1993). The effect of environmental enrichment on amphetaminestimulated locomotor activity, dopamine synthesis and dopamine release. Neuropharmacology 32, 885-893. doi: 10.1016/0028-3908 (93)90144-R
17. Burrows, E. L., McOmish, C. E., and Hannan, A. J. (2011). Geneenvironment interactions and construct validity in preclinical models of psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1376-1382. doi: 10.1016/j.pnpbp.2010.12.011
18. Canuso, C. M., and Pandina, G. (2007). Gender and schizophrenia. Psychopharmacol. Bull. 40, 178-190.
19. Carpenter, A. C., Saborido, T. P., and Stanwood, G. D. (2012). Development of hyperactivity and anxiety-like responses in dopamine transporter-defi{ligature}cient mice. Dev. Neurosci. 34, 250-257. doi: 10.1159/000336824
20. Casey, B. J., Getz, S., and Galvan, A. (2008). The adolescent brain. Dev. Rev. 28, 62-77. doi: 10.1016/j.dr.2007.08.003
21. Caspi, A., and Moffi{ligature}tt, T. E. (2006). Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 7, 583-590. doi: 10.1038/nrn1925
22. Caspi, A., Moffi{ligature}tt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 57, 1117-1127. doi: 10.1016/j.biopsych.2005.01.026
23. Chapillon, P., Manneche, C., Belzung, C., and Caston, J. (1999). Rearing environmental enrichment in two inbred strains of mice: 1. Effects on emotional reactivity. Behav. Genet. 29, 41-46. doi: 10.1023/A:1021437905913
24. Chen, Y.-J. (2007). Type III Neuregulin 1 Functions in the Central Nervous System. Ph.D. thesis, Columbia: Columbia University.
25. Chesworth, R., Downey, L., Logge, W., Killcross, S., and Karl, T. (2012a). Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav. Brain Res. 226, 218-223. doi: 10.1016/j.bbr.2011.09.019
26. Chesworth, R., Yulyaningsih, E., Cappas, E., Arnold, J., Sainsbury, A., and Karl, T. (2012b). The response of neuregulin 1 mutant mice to acute restraint stress. Neurosci. Lett. 515, 82-86. doi: 10.1016/j.neulet.2012.03.024
27. Corcoran, C., Walker, E., Huot, R., Mittal, V., Tessner, K., Kestler, L., et al. (2003). The stress cascade and schizophrenia: etiology and onset. Schizophr. Bull. 29, 671-692. doi: 10.1093/oxfordjournals.schbul.a007038
28. Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., and Angold, A. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry 60, 837-844. doi: 10.1001/archpsyc.60.8.837
29. D'Souza, D. C., Sewell, R. A., and Ranganathan, M. (2009). Cannabis and psychosis/schizophrenia: human studies. Eur. Arch. Psychiatry Clin. Neurosci. 259, 413-431. doi: 10.1007/s00406-009-0024-2
30. De Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., and Joels, M. (1998). Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19, 269-301. doi: 10.1210/er.19.3.269
31. Del Arco, A., Segovia, G., Canales, J. J., Garrido, P., de Blas, M., Garcia-Verdugo, J. M., et al. (2007). Environmental enrichment reduces the function of D1 dopamine receptors in the prefrontal cortex of the rat. J. Neural Transm. 114, 43-48. doi: 10.1007/s00702-006-0565-8
32. Desbonnet, L., O'Tuathaigh, C., Clarke, G., O'Leary, C., Petit, E., Clarke, N., et al. (2012). Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene x environment interaction. Brain Behav. Immun. 26, 660-671. doi: 10.1016/j.bbi.2012.02.010
33. Duffy, L., Cappas, E., Lai, D., Boucher, A. A., and Karl, T. (2010). Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 170, 800-807. doi: 10.1016/j.neuroscience.2010.07.042
34. Duffy, L., Cappas, E., Scimone, A., Schofi{ligature}eld, P. R., and Karl, T. (2008). Behavioral profi{ligature}le of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behav. Neurosci. 122, 748-759. doi: 10.1037/0735-7044.122.4.748
35. Dulawa, S. C., Grandy, D. K., Low, M. J., Paulus, M. P., and Geyer, M. A. (1999). Dopamine D4 receptorknock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 19, 9550-9556.
36. Duncan, G. E., Sheitman, B. B., and Lieberman, J. A. (1999). An integrated view of pathophysiological models of schizophrenia. Brain Res. Brain Res. Rev. 29, 250-264. doi: 10.1016/S0165-0173(99)00002-8
37. Favalli, G., Li, J., Belmonte-deAbreu, P., Wong, A. H., and Daskalakis, Z. J. (2012). The role of BDNF in the pathophysiology and treatment of schizophrenia. J. Psychiatr. Res. 46, 1-11. doi: 10.1016/j.jpsychires.2011.09.022
38. Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., et al. (2013). Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339, 1095-1099. doi: 10.1126/science.1228261
39. Grilli, M., Zappettini, S., Zanardi, A., Lagomarsino, F., Pittaluga, A., Zoli, M., et al. (2009). Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus. J. Neurochem. 110, 1598-1606. doi: 10.1111/j.1471-4159.2009.06265.x
40. Hahn, C. G., Wang, H. Y., Cho, D. S., Talbot, K., Gur, R. E., Berrettini, W. H., et al. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 12, 824-828. doi: 10.1038/nm1418
41. Han, S., Yang, B. Z., Kranzler, H. R., Oslin, D., Anton, R., Farrer, L. A., et al. (2012). Linkage analysis followed by association show NRG1 associated with Cannabis dependence in African Americans. Biol. Psychiatry 72, 637-644. doi: 10.1016/j.biopsych.2012.02.038
42. Harrison, P. J., and Law, A. J. (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 60, 132-140. doi: 10.1016/j.biopsych.2005.11.002
43. Herman, J. P., Mueller, N. K., and Figueiredo, H. (2004). Role of GABA and glutamate circuitry in hypothalamo-pituitaryadrenocortical stress integration. Ann. N.Y. Acad. Sci. 1018, 35-45. doi: 10.1196/annals.1296.004
44. Hintsanen, M., Elovainio, M., Puttonen, S., Kivimaki, M., Raitakari, O. T., Lehtimaki, T., et al. (2007). Neuregulin-1 genotype moderates the association between job strain and early atherosclerosis in young men. Ann. Behav. Med. 33, 148-155. doi: 10.1007/BF02879896
45. Horan, W. P., Ventura, J., Nuechterlein, K. H., Subotnik, K. L., Hwang, S. S., and Mintz, J. (2005). Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophr. Res. 75, 363-374. doi: 10.1016/j.schres.2004.07.019
46. Hultman, C. M., Wieselgren, I. M., and Ohman, A. (1997). Relationships between social support, social coping and life events in the relapse of schizophrenic patients. Scand. J. Psychol. 38, 3-13. doi: 10.1111/1467-9450.00002
47. Ibi, D., Nagai, T., Koike, H., Kitahara, Y., Mizoguchi, H., Niwa, M., et al. (2010). Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav. Brain Res. 206, 32-37. doi: 10.1016/j.bbr.2009.08.027
48. Javitt, D. C., and Coyle, J. T. (2004). Decoding schizophrenia. Sci. Am. 290, 48-55. doi: 10.1038/scientifi{ligature}camerican0104-48
49. Kapur, S., and Seeman, P. (2002). NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptorsimplications for models of schizophrenia. Mol. Psychiatry 7, 837-844. doi: 10.1038/sj.mp. 4001093
50. Karl, T., and Arnold, J. C. (2013). What does a mouse tell us about neuregulin 1-cannabis interactions? Front. Cell. Neurosci. 7:18. doi: 10.3389/fncel.2013.00018
51. Karl, T., Burne, T. H., Van den Buuse, M., and Chesworth, R. (2011). Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating defi{ligature}cit? Behav. Brain Res. 223, 336-341. doi: 10.1016/j.bbr.2011.04.051
52. Karl, T., Duffy, L., Scimone, A., Harvey, R. P., and Schofi{ligature}eld, P. R. (2007). Altered motor activity, exploration and anxiety-like in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav. 6, 677-687. doi: 10.1111/j.1601-183X.2006.00298.x
53. Keri, S., Kiss, I., Seres, I., and Kelemen, O. (2009). A polymorphism of the neuregulin 1 gene (SNP8NRG243177/rs6994992) affects reactivity to expressed emotion in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 418-420. doi: 10.1002/ajmg. b.30812
54. Koenig, J. I., Kirkpatrick, B., and Lee, P. (2002). Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27, 309-318. doi: 10.1016/S0893-133X(01)00396-7
55. Krishnan, V., Han, M. H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., et al. (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131, 391-404. doi: 10.1016/j.cell.2007.09.018
56. Laarakker, M., van Lith, H., and Ohl, F. (2011). Behavioral characterization of A/J and C57BL/6J mice using a multidimensional test: association between blood plasma and brain magnesium-ion concentration with anxiety-like. Physiol. Behav. 102, 205-219. doi: 10.1016/ j.physbeh.2010.10.019
57. Long, L. E., Chesworth, R., Arnold, J. C., and Karl, T. (2010). A followup study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology (Berl.) 211, 277-289. doi: 10.1007/s00213-010-1896-6
58. Long, L. E., Chesworth, R., Huang, X. F., McGregor, I. S., Arnold, J. C., and Karl, T. (2013). Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. Int. J. Neuropsychopharmacol. 16, 163-175. doi: 10.1017/ S1461145711001854
59. Long, L. E., Chesworth, R., Huang, X. F., Wong, A., Spiro, A., McGregor, I. S., et al. (2012). Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. PLoS ONE 7:e34129. doi: 10.1371/ journal.pone.0034129
60. Mackay-Sim, A., Feron, F., Eyles, D., Burne, T., and McGrath, J. (2004). Schizophrenia, vitamin D, and brain development. Int. Rev. Neurobiol. 59, 351-380. doi: 10.1016/S0074-7742(04)59014-1
61. Marenco, S., and Weinberger, D. R. (2000). The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 12, 501-527. doi: 10.1017/ S0954579400003138
62. McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., and Chant, D. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the infl{ligature}uence of sex, urbanicity, migrant status and methodology. BMC Med. 2:13. doi: 10.1186/1741-7015-2-13
63. McOmish, C. E., Burrows, E., Howard, M., Scarr, E., Kim, D., Shin, H. S., et al. (2008). Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol. Psychiatry 13, 661-672. doi: 10.1038/sj.mp. 4002046
64. Mei, L., and Xiong, W. C. (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437-452. doi: 10.1038/nrn2392
65. Mohn, A. R., Gainetdinov, R. R., Caron, M. G., and Koller, B. H. (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436. doi: 10.1016/ S0092-8674(00)81972-8
66. Munafo, M. R., Thiselton, D. L., Clark, T. G., and Flint, J. (2006). Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry 11, 539-546. doi: 10.1038/sj.mp.4001817
67. Ng, E., McGirr, A., Wong, A. H., and Roder, J. C. (2013). Using rodents to model schizophrenia and substance use comorbidity. Neurosci. Biobehav. Rev. 37, 896-910. doi: 10.1016/j.neubiorev.2013.03.025
68. Olsson, I. A., and Dahlborn, K. (2002). Improving housing conditions for laboratory mice: a review of "environmental enrichment. " Lab. Anim. 36, 243-270. doi: 10.1258/002367702320162379
69. O'Tuathaigh, C. M., Hryniewiecka, M., Behan, A., Tighe, O., Coughlan, C., Desbonnet, L., et al. (2010). Chronic adolescent exposure to Delta-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology 35, 2262-2273. doi: 10.1038/ npp.2010.100
70. O'Tuathaigh, C. M., O'Sullivan, G. J., Kinsella, A., Harvey, R. P., Tighe, O., Croke, D. T., et al. (2006). Sexually dimorphic changes in the exploratory and habituation profi{ligature}les of heterozygous neuregulin-1 knockout mice. Neuroreport 17, 79-83. doi: 10.1097/01.wnr. 0000192738.31029.0a
71. Owen, M. J., Craddock, N., and O'Donovan, M. C. (2005). Schizophrenia: genes at last? Trends Genet. 21, 518-525. doi: 10.1016/j.tig.2005.06.011
72. Ozaki, M., Sasner, M., Yano, R., Lu, H. S., and Buonanno, A. (1997). Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390, 691-694.
73. Paus, T., Keshavan, M., and Giedd, J. N. (2008). Why do many psychiatric disorders emerge during adolescence? Nat. Rev. Neurosci. 9, 947-957.
74. Rampon, C., Tang, Y. P., Goodhouse, J., Shimizu, E., Kyin, M., and Tsien, J. Z. (2000). Enrichment induces structural changes and recovery from nonspatial memory defi{ligature}cits in CA1 NMDAR1-knockout mice. Nat. Neurosci. 3, 238-244. doi: 10.1038/72945
75. Rapoport, J. L., Addington, A. M., Frangou, S., and Psych, M. R. (2005). The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10, 434-449. doi: 10.1038/sj.mp.4001642
76. Romeo, R. D., Bellani, R., Karatsoreos, I. N., Chhua, N., Vernov, M., Conrad, C. D., et al. (2006). Stress history and pubertal development interact to shape hypothalamicpituitary-adrenal axis plasticity. Endocrinology 147, 1664-1674. doi: 10.1210/en.2005-1432
77. Roy, V., Belzung, C., Delarue, C., and Chapillon, P. (2001). Environmental enrichment in BALB/c mice: effects in classical tests of anxiety-like and exposure to a predatory odor. Physiol. Behav. 74, 313-320. doi: 10.1016/ S0031-9384(01)00561-3
78. Sanders, A. R., Duan, J., Levinson, D. F., Shi, J., He, D., Hou, C., et al. (2008). No signifi{ligature}cant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 165, 497-506. doi: 10.1176/appi.ajp.2007.07101573
79. Smith, D. R., Striplin, C. D., Geller, A. M., Mailman, R. B., Drago, J., Lawler, C. P., et al. (1998). Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 86, 135-146. doi: 10.1016/ S0306-4522(97)00608-8
80. Spear, L. P. (2000). The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24, 417-463. doi: 10.1016/S0149-7634(00)00014-2
81. Spires, T. L., and Hannan, A. J. (2005). Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS anniversary prize lecture delivered on 27 June 2004 at the 29th FEBS congress in Warsaw. FEBS J. 272, 2347-2361. doi: 10.1111/j.1742-4658.2005.04677.x
82. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892. doi: 10.1086/342734
83. Stefansson, H., Steinthorsdottir, V., Thorgeirsson, T. E., Gulcher, J. R., and Stefansson, K. (2004). Neuregulin 1 and schizophrenia. Ann. Med. 36, 62-71. doi: 10.1080/07853890310017585
84. Taylor, S. B., Markham, J. A., Taylor, A. R., Kanaskie, B. Z., and Koenig, J. I. (2011a). Sex-specifi{ligature}c neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats. Behav. Brain Res. 224, 223-232. doi: 10.1016/j.bbr.2011.05.008
85. Taylor, S. B., Taylor, A. R., Markham, J. A., Geurts, A. M., Kanaskie, B. Z., and Koenig, J. I. (2011b). Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli. Physiol. Behav. 104, 205-214. doi: 10.1016/j.physbeh.2010.11.015
86. Taylor, S. B., Taylor, A. R., and Koenig, J. I. (2012). The interaction of disrupted Type II Neuregulin 1 and chronic adolescent stress on adult anxiety-like-and fearrelated behaviors. Neuroscience. doi: 10.1016/j.neuroscience.2012. 09.045. [Epub ahead of print].
87. Thompson, J. L., Pogue-Geile, M. F., and Grace, A. A. (2004). Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. Schizophr. Bull. 30, 875-900. doi: 10.1093/oxfordjournals.schbul.a007139
88. Ting, A. K., Chen, Y., Wen, L., Yin, D. M., Shen, C., Tao, Y., et al. (2011). Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J. Neurosci. 31, 15-25. doi: 10.1523/JNEUROSCI.2538-10.2011
89. Tosato, S., Dazzan, P., and Collier, D. (2005). Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophr. Bull. 31, 613-617. doi: 10.1093/schbul/sbi043
90. Trainor, B. C., Pride, M. C., Villalon Landeros, R., Knoblauch, N. W., Takahashi, E. Y., Silva, A. L., et al. (2011). Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse (Peromyscus californicus). PLoS ONE 6:e17405. doi: 10.1371/journal. pone.0017405
91. Tsuang, M. T., Bar, J. L., Stone, W. S., and Faraone, S. V. (2004). Gene-environment interactions in mental disorders. World Psychiatry 3, 73-83.
92. Tsuang, M. T., Stone, W. S., and Faraone, S. V. (2001). Genes, environment and schizophrenia. Br. J. Psychiatry Suppl. 40, s18-s24. doi: 10.1192/bjp.178.40.s18
93. Tucci, V., Lad, H., Parker, A., Polley, S., Brown, S., and Nolan, P. (2006). Gene-environment interactions differentially affect mouse strain behavioral parameters. Mamm. Genome 17, 1113-1120. doi: 10.1007/s00335-006-0075-x
94. Valdar, W., Solberg, L. C., Gauguier, D., Cookson, W. O., Rawlins, J. N. P., Mott, R., et al. (2006). Genetic and environmental effects on complex traits in mice. Genetics 174, 959-984. doi: 10.1534/genetics.106.060004
95. van Dellen, A., Blakemore, C., Deacon, R., York, D., and Hannan, A. J. (2000). Delaying the onset of Huntington's in mice. Nature 404, 721-722. doi: 10.1038/ 35008142
96. van den Buuse, M., Wischhof, L., Lee, R. X., Martin, S., and Karl, T. (2009). Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int. J. Neuropsychopharmacol. 12, 1383-1393. doi: 10.1017/ S1461145709000388
97. van Os, J., Kenis, G., and Rutten, B. P. (2010). The environment and schizophrenia. Nature 468, 203-212. doi: 10.1038/nature09563
98. van Venrooij, J. A., Fluitman, S. B., Lijmer, J. G., Kavelaars, A., Heijnen, C. J., Westenberg, H. G., et al. (2010). Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a fi{ligature}rst episode of psychosis. Schizophr. Bull. 38, 272-279. doi: 10.1093/schbul/ sbq062
99. van Winkel, R., Stefanis, N. C., and Myin-Germeys, I. (2008). Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull. 34, 1095-1105. doi: 10.1093/schbul/sbn101
100. Walker, E., and Bollini, A. M. (2002). Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophr. Res. 54, 17-23. doi: 10.1016/S0920-9964 (01)00347-4
101. Walker, E., Mittal, V., and Tessner, K. (2008). Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 4, 189-216. doi: 10.1146/annurev.clinpsy.4. 022007.141248
102. Walss-Bass, C., Liu, W., Lew, D. F., Villegas, R., Montero, P., Dassori, A., et al. (2006). A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol. Psychiatry 60, 548-553. doi: 10.1016/j.biopsych.2006.03.017
103. Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., and Kleinman, J. E. (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8, 592-610. doi: 10.1038/sj.mp.4001308
104. Wong, A. H., and Van Tol, H. H. (2003). Schizophrenia: from phenomenology to neurobiology. Neurosci. Biobehav. Rev. 27, 269-306. doi: 10.1016/S0149-7634(03)00035-6
105. Zammit, S., Owen, M. J., Evans, J., Heron, J., and Lewis, G. (2011). Cannabis, COMT and psychotic experiences. Br. J. Psychiatry 199, 380-385. doi: 10.1192/bjp.bp.111.091421
106. Zammit, S., Owen, M. J., and Lewis, G. (2010). Misconceptions about geneenvironment interactions in psychiatry. Evid. Based Ment. Health 13, 65-68. doi: 10.1136/ebmh1056
107. Zhe, D., Fang, H., and Yuxiu, S. (2008). Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats. Acta Histochem. Cytochem. 41, 89-95. doi: 10.1267/ahc.08013
108. Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., et al. (2001). Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. U.S.A. 98, 1982-1987. doi: 10.1073/pnas.98.4.1982